Cascade Prodrug Inc.
- Biotech or pharma, therapeutic R&D
Cascade is developing an IND stage hypoxia targeted prodrug initially targeting pancreatic cancer, GBM, and combination with an anti-CTLA4 checkpoint inhibitor.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}